Personalized Health and Related Technologies (PHRT) is a strategic focus area of the ETH Domain which encompasses six Swiss institutions: ETHZ, EPFL, PSI, Empa, Eawag and WSL. The main goal of PHRT is to drive the ongoing life science revolution that will ultimately transform medicine as it is today into ‘individualized medicine’. In essence, a person’s unique biological makeup will guide decisions on how to maintain and restore health. Thanks to its community of researchers and associated hospitals, PHRT is pushing the frontiers of knowledge on the mechanisms of diseases and opening the door to new treatments and technologies improving health and disease treatments.
A recent Nature Communications paper by the Snijder & Wollscheid groups (IMSB) in collaboration with the Theocharides (USZ), Lopes (UZH), and Skoda (USB) groups, describes drugs targeting cancerous stem cells
“Meet the Researcher” is a format that aims to introduce up-and-coming researchers through a short interview about their work, their experiences and their plans for the future.
“Meet the Researcher” is a format that aims to introduce up-and-coming researchers through a short interview about their work, their experiences and their plans for the future.
